Not Medicare Enrolled

Dr. Gregory Ferreira, MD

Pulmonary Disease · Sarasota, FL
Low-engagement
1843 FLOYD STREET, Sarasota, FL 34239
9419513920
In practice since 2006 (19 years)
NPI: 1790717908 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ferreira from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ferreira? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ferreira

Dr. Gregory Ferreira is a pulmonary disease in Sarasota, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Ferreira received a total of $8,286 from 63 pharmaceutical and/or device companies across 451 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ferreira is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $8,286 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$8,286
Total received (2018-2024)
Avg $1,184/year across 7 years
Top 25% in FL for pulmonary disease
63
Companies
451
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,201 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$85 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,340
2023
$1,076
2022
$1,039
2021
$1,150
2020
$1,143
2019
$1,274
2018
$1,264

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$912
Novo Nordisk Inc
$667
GlaxoSmithKline, LLC.
$529
Actelion Pharmaceuticals US, Inc.
$519
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$470
PFIZER INC.
$464
Takeda Pharmaceuticals U.S.A., Inc.
$391
Lilly USA, LLC
$310
Boehringer Ingelheim Pharmaceuticals, Inc.
$288
Janssen Pharmaceuticals, Inc
$250
United Therapeutics Corporation
$239
Exact Sciences Corporation
$181
Insmed, Inc.
$177
AstraZeneca Pharmaceuticals LP
$165
Jazz Pharmaceuticals Inc.
$161
Novartis Pharmaceuticals Corporation
$160
Paratek Pharmaceuticals, Inc.
$146
Genentech USA, Inc.
$139
Radius Health, Inc.
$122
IDORSIA PHARMACEUTICALS US INC
$113
Philips Electronics North America Corporation
$112
TETRAPHASE PHARMACEUTICALS, INC.
$103
Regeneron Healthcare Solutions, Inc.
$101
Bayer HealthCare Pharmaceuticals Inc.
$100
Allergan Inc.
$94
Shire North American Group Inc
$92
Gilead Sciences, Inc.
$81
Biohaven Pharmaceuticals, Inc.
$80
Antares Pharma, Inc.
$79
IBSA Pharma Inc.
$78
E.R. Squibb & Sons, L.L.C.
$67
AbbVie Inc.
$61
Astellas Pharma US Inc
$51
ABBVIE INC.
$48
Alnylam Pharmaceuticals Inc.
$48
Vanda Pharmaceuticals Inc.
$47
OptiNose US, Inc.
$44
Electromed, Inc.
$43
Circassia Pharmaceuticals Inc
$43
AbbVie, Inc.
$37
PORTOLA PHARMACEUTICALS, INC.
$36
UCB, Inc.
$35
Advanced Respiratory, Inc
$28
Aytu BioScience, Inc
$27
Mallinckrodt LLC
$24
Tactile Systems Technology Inc
$22
BOSTON SCIENTIFIC CORPORATION
$21
SHIELD THERAPEUTICS INC
$21
Merck Sharp & Dohme Corporation
$20
SANOFI PASTEUR INC.
$20
SANOFI-AVENTIS U.S. LLC
$19
Ambu Inc.
$19
Sunovion Pharmaceuticals Inc.
$19
Mallinckrodt Enterprises LLC
$19
Covis Pharma GmBH
$18
Eisai Inc.
$18
Allergan, Inc.
$17
Cleerly, Inc.
$17
Chiesi USA, Inc.
$16
Mylan Specialty L.P.
$14
Kowa Pharmaceuticals America, Inc.
$14
Avanir Pharmaceuticals, Inc.
$14
NESTLE HEALTHCARE NUTRITION INC.
$13
Top 3 companies account for 25.4% of total payments
Associated products mentioned in payments ›
(8874) inCourage · ACCRUFER · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · Adempas · Aimovig · Arikayce · BEVYXXA · BREZTRI · BYSTOLIC · CAMZYOS · CHANTIX · CLEVIPREX · CUVITRU · Cleerly Ischemia · Cologuard Collection Kit · Creon · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Esbriet · FARXIGA · FLUBLOK QUADRIVALENT · Flexitouch Plus · GATTEX · GLASSIA · HETLIOZ · HYQVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LONHALA MAGNAIR · Licart · Livalo · MOUNJARO · MYRBETRIQ · NUCALA · NUEDEXTA · NURTEC ODT · NUZYRA · Natesto · Nayzilam · OFEV · OFIRMEV · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Otezla · Otrexup · Ozempic · PAXLOVID · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR 20 · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SMARTVEST · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Synthroid · TEZSPIRE · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Tirosint · Tresiba · Trilogy 100 · Trintellix · Tuzistra XR · Tymlos · UBRELVY · UPTRAVI · VIIBRYD · VRAYLAR · Veklury · Victoza · WATCHMAN · XARELTO · XERAVA · XIFAXAN · XYOSTED · Xerava · Xhance · Xofluza · Xolair · YUPELRI · ZENPEP · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease in Sarasota?
Compare pulmonary diseases in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
31
Per 100K population
6.9
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ferreira is a pulmonary disease, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Ferreira receive payments from pharmaceutical companies?
Yes. Dr. Ferreira received a total of $8,286 from 63 companies across 451 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Ferreira) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →